首页|金昭胶囊对慢性酒精性肝损伤小鼠的保护作用

金昭胶囊对慢性酒精性肝损伤小鼠的保护作用

扫码查看
目的:基于Kelch样环氧氯丙烷相关蛋白1(Keap1)/核因子E2相关因子(Nrf2)/核因子κB通路研究金昭胶囊对慢性酒精性肝损伤小鼠的保护作用.方法:小鼠按体质量随机区组法分为空白组,模型组,阳性药组,金昭胶囊低、中、高剂量组,每组10只.除空白组外,其余各组小鼠每日灌胃50%乙醇10 mL/kg.各组持续给药4周后,观察小鼠状态,测定血清转氨酶活性、肝组织乙醇及脂肪代谢相关酶活性、抗氧化酶活性及Keap1/Nrf2/核因子κB通路相关指标并取肝脏进行苏木精-伊红(HE)病理学检查.结果:与模型组比较,金昭胶囊各剂量组小鼠血清转氨酶活性、肝组织乙醇及脂肪代谢相关酶活性、抗氧化酶水平、炎症介质中白细胞介素-10(IL-10)水平、Nrf2 mRNA水平及Nrf2、血红素加氧酶1(HO-1)表达水平均显著升高(P<0.05、P<0.01);肝组织炎症介质中肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)水平、Keap1mRNA、核因子κB亚基p65亲和肽(NF-κB p65)mRNA水平及Keap1、NF-κB p65和磷酸化核因子κB抑制蛋白α(pIκ-Bα)表达均显著降低(P<0.05、P<0.01).结论:金昭胶囊具有保护慢性酒精性肝损伤的功效,其作用机制可能与增强肝组织中乙醇代谢酶、抗氧化酶活性,调节炎症介质水平和Keap1/Nrf2/核因子κB通路各指标mRNA及蛋白表达水平相关.
Jinzhao Capsules Protect Mice from Chronic Alcoholic Liver Injury
Objective:To decipher the mechanism of Jinzhao Capsules in protecting mice from chronic alcoholic liver injury via the Kelch-like ECH-associated protein-1/nuclear factor erythroid 2-related factor 2/nuclear factor-κB(Keap1/Nrf2/NF-κB)pathway.Methods:Mice were randomized into blank,model,positive drug,and low-,medium-,and high-dose Jinzhao Capsules groups(n=10)according to their body weights.The mice in the other groups except the blank group were administrated with 50%ethanol at a dose of 10 mL/kg by gavage every day.After four consecutive weeks of drug administration,the status of mice was observed,and the activity of transaminase in the serum as well as the levels of ethanol,fat metabolism-related enzymes,and antioxidant enzymes in the liver were measured.In addition,the protein and mRNA levels of factors in the Keap1/Nrf2/NF-κB pathway were determined.The liver tissue was sampled and stained with hematoxylin and eosin,and the pathological changes were examined.Results:Com-pared with the model group,Jinzhao Capsules groups showed increased transaminase activity in the serum,elevated levels of etha-nol,fat metabolism-related enzymes,antioxidant enzymes,and interleukin-10(IL-10)in the liver,up-regulated mRNA level of Nrf2 and protein levels of Nrf2 and heme oxygenase-1(P<0.05,P<0.01),lowered levels of tumor necrosis factor-α and interleukin-6,and down-regulated mRNA levels of Keap1 and NF-κB p65 and protein levels of Keap1,NF-κB p65,phospho-inhibitory subunit of NF-κB α in the liver(P<0.05,P<0.01).Conclusion:Jinzhao Capsules can protect mice from chronic alcoholic liver injury by enhancing the activities of alcohol metabolism-related enzymes and antioxidant enzymes in the liver tissue and regulating the levels of inflammatory mediators and the mRNA and protein levels of factors in the Keap1/Nrf2/NF-κB pathway.

Jinzhao CapsulesAlcoholic liver injuryEthanol metabolismFat metabolismInflammatory mediatorsOxidative stressKelch-like ECH-associated protein-1/nuclear factor erythroid 2-related factor 2/nuclear factor-KB(Keap1/Nrf2/NF-κB)Mice

贾岚、高晶、李丽、邵紫萱、扈觐玺、刘佳琪、冯广旭、王景霞

展开 >

北京中医药大学,北京,100029

金昭胶囊 酒精性肝损伤 乙醇代谢 脂肪代谢 炎症介质 氧化应激 Kelch样环氧氯丙烷相关蛋白1/核因子E2相关因子/核因子κB 小鼠

国家自然科学基金项目国家中医药管理局中医药行业科研专项

82074036201507004

2024

世界中医药
世界中医药学会联合会

世界中医药

CSTPCDCHSSCD北大核心
影响因子:1.266
ISSN:1673-7202
年,卷(期):2024.19(12)